Welcome to our dedicated page for Sapiens Interntl news (Ticker: SPNS), a resource for investors and traders seeking the latest updates and insights on Sapiens Interntl stock.
Sapiens International Corporation N.V., historically listed as SPNS on Nasdaq and the Tel Aviv Stock Exchange, generates a steady stream of news around its role as a global provider of intelligent SaaS-based software solutions for the insurance industry. Its announcements highlight how insurers use Sapiens platforms to modernize core systems, apply AI and automation, and manage complex underwriting, claims, and policy administration tasks.
News items for Sapiens commonly cover product launches and upgrades, such as new versions of CoreSuite for Property & Casualty, enhancements to workers’ compensation solutions, and major releases like the Decision Analytics module within the Sapiens Decision platform. These updates often describe new capabilities in AI-driven underwriting, real-time analytics, and digital workflows for insurers.
The company also issues releases on customer projects and partnerships. Examples include upgrades of IDITSuite for organizations like the Medical Protection Society, implementations of Automated Testing Services for Encova Insurance, and strategic partnerships such as the collaboration with Linqura for P&C underwriting risk-scoring. These stories show how insurers apply Sapiens software to improve efficiency, testing, and risk selection.
Another important category of SPNS-related news involves corporate and capital markets developments. In 2025, Sapiens announced a definitive agreement to be acquired by Advent and later confirmed the closing of the merger, after which its common stock ceased trading and the company began the process of delisting and deregistration. Additional filings and releases address topics like early redemption of Series B debentures and shareholder approvals at an Extraordinary General Meeting.
Investors and industry followers can use this news feed to review historical earnings announcements, product roadmaps, customer case studies, and the details of Sapiens’ transition from a publicly traded company under the SPNS symbol to a privately held business under Advent’s ownership.
Sapiens International (NASDAQ: SPNS) hosted its North America Customer Summit in Austin, Texas on September 9-11, 2024, drawing 545 participants from 115 insurance companies, customers, and partners. The event featured keynotes and sessions from industry experts at Microsoft, Deloitte, Celent, and Datos Insights and included presentations on Sapiens' latest product developments and roadmaps across lines of business.
Highlights included a keynote by Josh Linkner, a presentation on generative AI by Dr. Tomer Simon of Microsoft, and a Deloitte fireside chat on modern insurance platform ecosystems. Sponsors included Microsoft, Deloitte, Swiss Re and other industry vendors.
Sapiens (NASDAQ:SPNS) announced senior leadership appointments after Advent completed its acquisition, which closed on Dec 17, 2025 following shareholder approval on Nov 19, 2025 and required regulatory clearances. Sapiens common stock has ceased trading and the company will operate privately under Advent ownership, with Formula retaining a minority stake.
Founder and long-time CEO Roni Al-Dor will step down as CEO and President effective Dec 31, 2025. Mike Ettling (Operating Partner, Advent) is appointed Executive Chairman and interim CEO. New appointments effective Dec 17 include Paul Wheeler (CFO), Dr. Ernesto Marinelli (Chief People Success Officer) and James Hannay (Chief Revenue Officer). Sapiens reported growth from $45m revenue to $542m in 2024 during Roni Giladi’s CFO tenure.
Sapiens (NASDAQ: SPNS) reported Q3 2025 results for the quarter ended September 30, 2025. Revenue reached $152.3M, up 11.2% YoY. GAAP gross profit was $67.3M (+11.6%) and non-GAAP gross profit was $70.7M (+12.5%). GAAP net income attributable to shareholders was $14.3M (-22.0%) with GAAP diluted EPS $0.25 (-24.2%). Non-GAAP operating profit was $25.5M with a 16.7% non-GAAP operating margin.
ARR totaled $220M, up 26.7% YoY (17.5% organic, 9.2% from acquisitions). The company disclosed a definitive acquisition agreement with Advent at $43.50 per share, valuing Sapiens at approximately $2.5B, and will forgo a Q3 2025 earnings call.
Sapiens (NASDAQ: SPNS; TASE: SPNS) said it will report third quarter 2025 financial results on November 13, 2025. The company reminded investors of a previously announced transaction: on August 12, 2025 Sapiens entered a definitive agreement to be acquired by Advent for $43.50 per common share in cash, valuing Sapiens at approximately $2.5 billion.
This release provides the earnings date and reconfirms the signed acquisition agreement and stated deal consideration.
Sapiens (NASDAQ: SPNS) held its North America Customer Summit in Phoenix, Arizona on October 27–29, 2025, drawing about 540 participants from 130 insurance and partner companies. The event theme, "Rising Beyond Limits," framed sessions on innovation, collaboration, and transformative insurance technology.
Keynotes and panels featured speakers from Microsoft, Deloitte, Celent, Datos Insights, and Sapiens leaders, covering agentic AI, market shifts, customer expectations, and strategic product roadmaps. Sapiens executives unveiled product updates across lines of business, and sponsors included Microsoft, Deloitte, InvoiceCloud, GhostDraft and others.
Sapiens (NASDAQ: SPNS) launched Decision Analytics, a new module within the Sapiens Decision Platform on October 28, 2025. The module provides real-time visibility into decision execution, captures detailed outcome and logic data, and connects decision data to analytics and BI environments to enable monitoring, natural-language queries, scenario testing, and continuous optimization.
Decision Analytics forms the foundation for OptimizeAI, which will add predictive and prescriptive optimization to move enterprises from manual tuning to semi-autonomous decision improvement.
Sapiens (NASDAQ: SPNS) announced Underwriting Workbench v3.0 on October 9, 2025, now available in EMEA and North America. The release converts a pre-bind underwriting tool into an intelligent business platform with non-linear workflows, role-specific interfaces (Action, Performance, Manager, Admin), deep Microsoft Outlook and Teams integration, real-time customizable analytics, and AI-driven insights to speed decisions and reduce manual work. The launch targets expansion from the London Market into the U.S. and Canadian P&C markets and emphasizes portfolio-driven decision intelligence for underwriters and managers.
Sapiens (NASDAQ: SPNS) announced a strategic partnership with Linqura on October 8, 2025 to embed Linqura's agentic-AI underwriting advisor into Sapiens PolicyPro for P&C policy administration.
The pre-integrated solution supplies secure, AI-driven underwriting insights for new business and renewals, including access to hundreds of U.S. business data points, real-time coverage recommendations, and Linqura's 1,100+ NAICS code classification to guide risk selection and pricing.
The collaboration aims to help commercial underwriters make more precise risk decisions, improve pricing confidence, and simplify commercial insurance workflows.
Sapiens International Corporation (NASDAQ: SPNS) has successfully completed a major upgrade of IDITSuite for Medical Protection Society (MPS), the world's leading protection organization for healthcare professionals. The upgrade advanced MPS' core suite by six versions, delivering future-proof architecture and extended lifecycle support.
The strategic enhancement brings four key benefits: future-proof architecture, extended lifecycle support, enhanced functionality, and improved performance and security. The project was completed within budget and on time, strengthening the long-term partnership between Sapiens and MPS.
Sapiens International (NASDAQ: SPNS) announced the first implementation of its Automated Testing Services (ATS) with Encova Insurance. The service enhances Encova's existing CoreSuite for Workers' Compensation solution by streamlining testing processes and improving software quality.
The implementation leverages Microsoft Playwright and includes pre-built automated regression test suites customized to Encova's operational environment. The project, which began in April 2025, aims to support Encova's next upgrade in October, promising reduced testing time, improved release quality, and freed internal resources for strategic initiatives.
FAQ
What is the current stock price of Sapiens Interntl (SPNS)?
What is the market cap of Sapiens Interntl (SPNS)?
